Загрузка страницы

How do Provenge or Xofigo Prolong Life When They Don’t Drop PSA?

PCRI’s Executive Director, Mark Scholz, MD, explains why Provenge and Xofigo are considered effective treatments for prostate cancer regardless of whether they cause a PSA drop—contrary to most other prostate cancer treatments in which PSA drop indicates efficacy.

0:18 Provenge is an FDA approved immune therapy, and Xofigo is a targeted form of injectable radiation that targets bone metastases. Both agents are capable of causing a PSA decline and extending life; however, unlike all other prostate cancer treatments,​ they can also extend life without causing a concurrent PSA drop. This has caused some to doubt their efficacy.

1:02 Rigorous studies have confirmed that Provenge and Xofigo are efficacious, so there should be no doubts in that regard. Traditional treatments like Chemotherapy and hormone therapy work by killing cancer cells for as long as they are being administered and then stop working when the treatment has ceased. Provenge and Xofigo, on the other hand, have long term anti-cancer effects. Provenge, for example, permanently alters the immune system to be more adept at fighting prostate cancer. It will not kill large portions of the disease like chemotherapy, but it will train the immune system to slow the progression of the disease. Even if there is not a PSA drop after Provenge or Xofigo, there may be a decline in its rate of increase.

2:19 These new technologies and treatments are effective despite their lack of performance on traditional metrics. Rigorous studies have confirmed that they increase longevity, and the lack of a PSA drop should not be taken as an indication that the agents are not working.

Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org

To learn more about prostate cancer visit http://www.pcri.org

To download the free Staging Guide visit http://www.pcri.org/prostate-cancer-s...

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call our free helpline at 1 (800) 641-7274 with any questions that you have. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.

The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.

#ProstateCancer #Prostate #MarkScholzMD

Видео How do Provenge or Xofigo Prolong Life When They Don’t Drop PSA? канала Prostate Cancer Research Institute
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
17 июня 2019 г. 21:00:07
00:03:10
Другие видео канала
PSA Recurrence: When Should You Treat? | Ask a Prostate Expert, Mark Scholz, MDPSA Recurrence: When Should You Treat? | Ask a Prostate Expert, Mark Scholz, MDHow Much Safer is Modern Radiation Therapy? | Answering YouTube Comments #63 | Mark Scholz, MDHow Much Safer is Modern Radiation Therapy? | Answering YouTube Comments #63 | Mark Scholz, MDComparing the Second Generation Hormone Therapies | Ask a Prostate Expert, Mark Scholz, MDComparing the Second Generation Hormone Therapies | Ask a Prostate Expert, Mark Scholz, MDGleason 4+4=8 Prostate Cancer Treatments | Ask a Prostate Expert, Mark Scholz, MDGleason 4+4=8 Prostate Cancer Treatments | Ask a Prostate Expert, Mark Scholz, MDRecurrent and Advanced Prostate Cancer | Answering Youtube Comments #5, The PCRIRecurrent and Advanced Prostate Cancer | Answering Youtube Comments #5, The PCRIIntermittent Hormone Therapy for Prostate Cancer 101 | Ask a Prostate Expert, Mark Scholz, MDIntermittent Hormone Therapy for Prostate Cancer 101 | Ask a Prostate Expert, Mark Scholz, MDSalvage Radiation, Lutetium-177, 3+4=7, & What is Cribriform? | Mark Scholz, MD | PCRISalvage Radiation, Lutetium-177, 3+4=7, & What is Cribriform? | Mark Scholz, MD | PCRIDiagnosis Without Biopsy, Lymph Nodes, 2nd Gen Hormone Treatments | Answering YouTube Comments #4Diagnosis Without Biopsy, Lymph Nodes, 2nd Gen Hormone Treatments | Answering YouTube Comments #4How a new aristocracy's segregation puts stress on societyHow a new aristocracy's segregation puts stress on societyDoes Sugar Feed Prostate Cancer? Does Fatty/Adipose Tissue Attract Cancer? | Mark Moyad, MD, MPHDoes Sugar Feed Prostate Cancer? Does Fatty/Adipose Tissue Attract Cancer? | Mark Moyad, MD, MPHOrgovyx, Nubeqa, & Early Taxotere | 2021Treatments In Review | Mark Scholz, MDOrgovyx, Nubeqa, & Early Taxotere | 2021Treatments In Review | Mark Scholz, MDPSA After Radiation | Ask a Prostate Expert, Mark Scholz, MDPSA After Radiation | Ask a Prostate Expert, Mark Scholz, MDUnorthodox Treatments for Recurrent Prostate Cancer (Indigo Stage) | Prostate Cancer Staging GuideUnorthodox Treatments for Recurrent Prostate Cancer (Indigo Stage) | Prostate Cancer Staging GuidePSMA/PET Scans: FDA Approved | Ask A Prostate Expert, Mark Scholz, MDPSMA/PET Scans: FDA Approved | Ask A Prostate Expert, Mark Scholz, MDWhat is Nubeqa for Prostate Cancer and How Does it Work? | Ask a Prostate Expert, Mark Scholz, MDWhat is Nubeqa for Prostate Cancer and How Does it Work? | Ask a Prostate Expert, Mark Scholz, MDNewly Diagnosed Prostate Cancer: What You Need to Know | Ask a Prostate Expert, Mark Scholz, MDNewly Diagnosed Prostate Cancer: What You Need to Know | Ask a Prostate Expert, Mark Scholz, MDImmunotherapy in 2022: Provenge, Keytruda, Car-T, and Leukine for Prostate Cancer | Mark Scholz, MDImmunotherapy in 2022: Provenge, Keytruda, Car-T, and Leukine for Prostate Cancer | Mark Scholz, MDImmune Therapy: Future Game Changers In Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MDImmune Therapy: Future Game Changers In Prostate Cancer | Ask a Prostate Expert, Mark Scholz, MDHow Radiation Affects The Prostate | Mark Scholz, MDHow Radiation Affects The Prostate | Mark Scholz, MDWhat is PROVENGE? Learn about Immunotherapy for Prostate CancerWhat is PROVENGE? Learn about Immunotherapy for Prostate Cancer
Яндекс.Метрика